MCLA-129

· Betta Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for MCLA-129, covering 2025-03-20 to 2026-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Study of MCLA-129 in Combination With Ensartinib in Patients With Advanced Solid Tumors. [Phase 1, Phase 2]